STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

March 13, 2026

Period of Report

March 11, 2026

Accession Number

0002064832-26-000141